Literature DB >> 22521487

Gadolinium loaded nanoparticles in theranostic magnetic resonance imaging.

Yongjun Liu1, Na Zhang.   

Abstract

Theranostic magnetic resonance imaging (MRI) is now receiving a growing interest in imaging-guided drug delivery, monitoring the treatment and personalized administration etc. Theranostic agents are essential for the usage of theranostic MRI. Among different kinds of theranostic agents, gadolinium loaded nanoparticles (GdNPs) are one of the most promising theranostic agents which are very promising in combination of diagnostics (molecular imaging) and therapeutics (molecular therapy) functions in a single platform. In this review, we provided fully discussion on the design considerations of GdNPs as a platform for theranostic MRI. The mainly factors that affect the preparation process, such as GdNP materials, the loading of Gd/drugs in GdNPs, and the passive and active targeting strategies were discussed. Major classes of GdNPs including lipid-based nanoparticles, polymeric nanoparticles, micelles, dendrimers and Gd-silica nanoparticles were described in detail. The use of GdNPs as theranostic agents offers potential advantages that change the usual cancer therapy from separating diagnosis and treatment to theranostic approach.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521487     DOI: 10.1016/j.biomaterials.2012.03.084

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  30 in total

1.  A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging.

Authors:  Zhuxian Zhou; Zhen Han; Zheng-Rong Lu
Journal:  Biomaterials       Date:  2016-02-03       Impact factor: 12.479

Review 2.  Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes.

Authors:  Rammohan Devulapally; Ramasamy Paulmurugan
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-08-31

3.  Theranostic magnetic resonance imaging of type 1 diabetes and pancreatic islet transplantation.

Authors:  Ping Wang; Anna Moore
Journal:  Quant Imaging Med Surg       Date:  2012-09

4.  Dual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents.

Authors:  X Luo; B Li; X Zhang; W Zhao; A Bratasz; B Deng; D W McComb; Y Dong
Journal:  Nanoscale       Date:  2017-01-26       Impact factor: 7.790

5.  Research into europium complexes as magnetic resonance imaging contrast agents (Review).

Authors:  Guocan Han; Yangwei Deng; Jihong Sun; Jun Ling; Zhiquan Shen
Journal:  Exp Ther Med       Date:  2015-02-17       Impact factor: 2.447

6.  Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents.

Authors:  Ching-Hui Huang; Kido Nwe; Ajlan Al Zaki; Martin W Brechbiel; Andrew Tsourkas
Journal:  ACS Nano       Date:  2012-10-29       Impact factor: 15.881

7.  Gd-labeled glycol chitosan as a pH-responsive magnetic resonance imaging agent for detecting acidic tumor microenvironments.

Authors:  Kido Nwe; Ching-Hui Huang; Andrew Tsourkas
Journal:  J Med Chem       Date:  2013-10-03       Impact factor: 7.446

8.  Mechanisms of Gadographene-Mediated Proton Spin Relaxation.

Authors:  Andy H Hung; Matthew C Duch; Giacomo Parigi; Matthew W Rotz; Lisa M Manus; Daniel J Mastarone; Kevin T Dam; Colton C Gits; Keith W Macrenaris; Claudio Luchinat; Mark C Hersam; Thomas J Meade
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2013-08-08       Impact factor: 4.126

9.  Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.

Authors:  Zhuxian Zhou; Xueming Wu; Adam Kresak; Mark Griswold; Zheng-Rong Lu
Journal:  Biomaterials       Date:  2013-07-14       Impact factor: 12.479

Review 10.  Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles.

Authors:  William T Phillips; Ande Bao; Andrew J Brenner; Beth A Goins
Journal:  Adv Drug Deliv Rev       Date:  2014-07-09       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.